FDA Adverse Event Malfunction Summary report: N

SESTAMIBI-R-

MDR report key: 2240771 · Received September 2, 2011

Report

Report Number
MW5022124
Event Type
Malfunction
Date Received
September 2, 2011
Date of Event
August 24, 2011
Report Date
September 2, 2011
Manufacturer
PHARMALOGIC
Product Code
KTA
Product Problem
Yes
Report Source
Voluntary report
Reporter Location
NY, US
Reporter Occupation
PHARMACIST

Narratives

Description of Event or Problem · 1

(B)(6) REPORTED ON (B)(6) 2011 THAT THEY WERE AWARE OF A ALTERED BIODISTRIBUTION ISSUE WITH SESTAMIBI-R- DUE TO A GENERATOR MALFUNCTION. LOT AFFECTED WAS 1134. PRODUCT PASSED THE COMPANY'S QI AND ASSAYED FOR THE CORRECT AMOUNTS OF SESTAMIBI-R-. HOWEVER, AFFECTED PT'S HEART WAS UNABLE TO BE VISUALIZED ON NUCLEAR SCAN DURING CARDIAC STRESS TESTING DUE TO THE INCREASED UPTAKE BY OF THE RADIOISOTOPE BY THE STOMACH AND BOWEL. PATIENT DID NOT SUFFER ANY HARM, BUT IS INCONVENIENCED BY HAVING THE TEST REPEATED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 SESTAMIBI-R- SESTAMIBI-R- KTA PHARMALOGIC 1134

Patients

Seq Age Sex Outcome Treatment
1 45 YR Other